Your support today will mean we are here for patients tomorrow.
Donate
Peter Meadowcroft kindly chose to fundraise for PCA during his time as Puckrup Hall Golf Club Captain in 2019 and here, he tells us his inspiring story. Puckrup Hall Golf Club is set in beautiful parkland with magnificent views of the Malvern Hills. Our…Read More
on 16th January
The UK’s first convergence science centre has opened in the UK! This will bring together scientists from multiple research areas to investigate new cancer treatment paths, including a treatment for pancreatic cancer. Cancer Research UK have teamed up with the…Read More
on 12th August
Ali Stunt, our CEO and president of Pancreatic Cancer Europe (PCE), explains the new PCE heatmap and what this means for pancreatic cancer! I am a founding board member of Pancreatic Cancer Europe (PCE) and currently its President. PCE is…Read More
on 9th August
New research from UCL School of Pharmacy revealed amongst 25-34 year olds, 51% would feel comfortable talking to their community pharmacist when experiencing symptoms of cancer, “if IT systems could enhance their case finding and clinical judgements.” In the report,…Read More
on 24th July
The cancer recovery package was first introduced in 2016 with the aim to improve quality of care for anyone with a cancer diagnosis. What is a recovery package? It was created in collaboration with Macmillan Cancer Support and aims to…Read More
on 8th July
We are excited to announce the launch of our new website section dedicated to healthcare professionals! Written by healthcare professionals, for healthcare professionals. The aim of the site is to clearly provide information and resources to healthcare professionals on pancreatic cancer…Read More
on 12th June
This all-day event will be taking place at The Royal Liverpool University Hospital on the 17th May from 8:30am. Who can attend? People whom have been affected by pancreatic disease, including pancreatic cancer, are invited to attend the 6th National…Read More
on 11th April
You may have heard of pancreatic cancer before, however, it is actually classed as a rare disease. Shockingly, under 7% of people diagnosed with the disease will survive just 5 years. This is due to the symptoms being vague and…Read More
on 28th February
Creon 40,000 will not be available from June 2019 If you have been prescribed Creon, we would like to inform you that Mylan the marketing authorisation holder for Creon, has decided to voluntarily discontinue the manufacture and distribution of Creon…Read More
on 25th February